Derek Maetzold

757 total citations
18 papers, 539 citations indexed

About

Derek Maetzold is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Derek Maetzold has authored 18 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Surgery. Recurrent topics in Derek Maetzold's work include Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (9 papers) and Immunotherapy and Immune Responses (3 papers). Derek Maetzold is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Melanoma and MAPK Pathways (9 papers) and Immunotherapy and Immune Responses (3 papers). Derek Maetzold collaborates with scholars based in United States. Derek Maetzold's co-authors include Kristen M. Oelschlager, Robert W. Cook, Clare Johnson, John F. Stone, Jeff Wilkinson, Pedram Gerami, Keith A. Delman, Rodabe N. Amaria, René González and David H. Lawson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Derek Maetzold

18 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek Maetzold United States 9 433 340 99 97 54 18 539
Jeff Wilkinson United States 7 356 0.8× 279 0.8× 83 0.8× 93 1.0× 51 0.9× 10 445
Clare Johnson United States 9 498 1.2× 385 1.1× 123 1.2× 100 1.0× 31 0.6× 21 613
Chelsea Cooper United States 10 407 0.9× 259 0.8× 105 1.1× 72 0.7× 27 0.5× 12 500
Kristen M. Oelschlager United States 12 517 1.2× 421 1.2× 123 1.2× 174 1.8× 167 3.1× 26 718
Beth Blondin United States 6 453 1.0× 299 0.9× 48 0.5× 71 0.7× 34 0.6× 6 546
Veronica Höiom Sweden 15 416 1.0× 347 1.0× 62 0.6× 115 1.2× 110 2.0× 34 656
Linda Potter United Kingdom 7 220 0.5× 350 1.0× 26 0.3× 53 0.5× 29 0.5× 9 450
Annelies Klaasen Netherlands 7 188 0.4× 170 0.5× 39 0.4× 53 0.5× 190 3.5× 8 396
Rita G Ladstein Norway 8 219 0.5× 192 0.6× 22 0.2× 72 0.7× 9 0.2× 8 345
Judith Kohlmeyer Germany 7 439 1.0× 332 1.0× 21 0.2× 374 3.9× 14 0.3× 7 737

Countries citing papers authored by Derek Maetzold

Since Specialization
Citations

This map shows the geographic impact of Derek Maetzold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Maetzold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Maetzold more than expected).

Fields of papers citing papers by Derek Maetzold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Maetzold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Maetzold. The network helps show where Derek Maetzold may publish in the future.

Co-authorship network of co-authors of Derek Maetzold

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Maetzold. A scholar is included among the top collaborators of Derek Maetzold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Maetzold. Derek Maetzold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ferris, Laura K., Aaron S. Farberg, Brooke Middlebrook, et al.. (2017). Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification. Journal of the American Academy of Dermatology. 76(5). 818–825.e3. 41 indexed citations
2.
Rienzo, Assunta De, Robert W. Cook, Jeff Wilkinson, et al.. (2016). Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues. Journal of Molecular Diagnostics. 19(1). 65–71. 8 indexed citations
3.
Berger, Adam C., Robert S. Davidson, Indy Chabra, et al.. (2016). Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Current Medical Research and Opinion. 32(9). 1599–1604. 51 indexed citations
4.
Cook, Robert W., Tony Tsai, Yevgeniy Shildkrot, et al.. (2016). Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study. Journal of Oncology. 2016. 1–9. 36 indexed citations
5.
Meldi, Kristen, Robert W. Cook, Tony Tsai, et al.. (2016). A prospective, multi-center study to evaluate the performance and clinical utility of a 15-gene expression profile for uveal melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9575–9575. 1 indexed citations
6.
Zager, Jonathan S., Jane L. Messina, Vernon K. Sondak, et al.. (2016). Performance of a 31-gene expression profile in a previously unreported cohort of 334 cutaneous melanoma patients.. Journal of Clinical Oncology. 34(15_suppl). 9581–9581. 8 indexed citations
7.
Gerami, Pedram, Robert W. Cook, Maria C. Russell, et al.. (2015). Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. Journal of the American Academy of Dermatology. 72(5). 780–785.e3. 116 indexed citations
8.
Gerami, Pedram, Robert W. Cook, Jeff Wilkinson, et al.. (2015). Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma. Clinical Cancer Research. 21(1). 175–183. 194 indexed citations
9.
Shan, Weiwei, Daniel C. Rosen, Natalie Lassen, et al.. (2015). Prospective prediction of resistance to neoadjuvant therapy in patients with locoregional esophageal adenocarcinoma. 53–53. 1 indexed citations
10.
Lawson, David H., Robert W. Cook, Clare Johnson, et al.. (2015). Continued evaluation of a 31-gene expression profile test (GEP) for prediction of distant metastasis (DM) in cutaneous melanoma (CM).. Journal of Clinical Oncology. 33(15_suppl). 9066–9066. 6 indexed citations
11.
Cook, Robert W., et al.. (2014). Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses. Clinical ophthalmology. 8. 2449–2449. 32 indexed citations
12.
Lee, Jong Woo, Andrew D. Norden, Keith L. Ligon, et al.. (2014). Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: A gene expression imaging study. Epilepsy Research. 108(5). 843–852. 16 indexed citations
13.
Badve, Sunil, Weiwei Shan, Clare Johnson, et al.. (2014). A proprietary multi-analyte test to predict neoadjuvant treatment response for esophageal and rectal adenocarcinoma patients.. Journal of Clinical Oncology. 32(15_suppl). 4085–4085. 1 indexed citations
14.
Lawson, David H., Maria C. Russell, Jeff Wilkinson, et al.. (2014). Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).. Journal of Clinical Oncology. 32(15_suppl). 9022–9022. 2 indexed citations
15.
Gökmen‐Polar, Yesim, Robert W. Cook, Chirayu Goswami, et al.. (2013). A Gene Signature to Determine Metastatic Behavior in Thymomas. PLoS ONE. 8(7). e66047–e66047. 21 indexed citations
16.
Lawson, David H., Maria C. Russell, Jeffrey Wilkinson, et al.. (2013). Gene expression profile of primary cutaneous melanomas to distinguish between low and high risk of metastasis.. Journal of Clinical Oncology. 31(15_suppl). 9022–9022. 2 indexed citations
17.
Dhillon, Navneet K., Keith A. Delman, Derek Maetzold, et al.. (2012). Gene expression profile signature (DecisionDx-Melanoma) to predict visceral metastatic risk in patients with stage I and stage II cutaneous melanoma.. Journal of Clinical Oncology. 30(15_suppl). 8543–8543. 2 indexed citations
18.
Gökmen‐Polar, Yesim, Chirayu Goswami, Robert W. Cook, et al.. (2012). A 19-gene prognostic GEP signature (DecisionDx-Thymoma) to determine metastatic risk associated with thymomas.. Journal of Clinical Oncology. 30(15_suppl). 7106–7106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Wilkinson Breakdown of academic impact, for papers by Clare Johnson Breakdown of academic impact, for papers by Chelsea Cooper Breakdown of academic impact, for papers by Kristen M. Oelschlager Breakdown of academic impact, for papers by Beth Blondin Breakdown of academic impact, for papers by Veronica Höiom Breakdown of academic impact, for papers by Linda Potter Breakdown of academic impact, for papers by Annelies Klaasen Breakdown of academic impact, for papers by Rita G Ladstein Breakdown of academic impact, for papers by Judith Kohlmeyer
Rankless by CCL
2026